FDA
-
-
-
-
-
-
-
Acorda Therapeutics (ACOR) Receives Positive CHMP Opinion for INBRIJA
-
-
-
-
-
-
-
Acorda Therapeutics Announces Commercial Launch of INBRIJAâ„¢ (levodopa inhalation powder)
-
-
-
-
-
-
-
Goldman Isn't Excited About Acorda Therapeutics (ACOR) Inbrija Approval, Reit Sell
-
-
-
-
-
-
-
Acorda Provides Financial and Pipeline Update for Third Quarter 2018
-
-
-
-
-
-
-
Pre-Open Movers 09/13: (PI) (XBIT) (GNC) Higher; (PVTL) (PGNX) (FRED) Lower (more...)
-
-
-
-
-
-
-
Acorda Provides Financial and Pipeline Update for Second Quarter 2018
-
-
-
-
-
-
-
Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018
-
251,245 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All